Press release
Febuxostat Market will reach 1590 million US$ in 2023
Febuxostat can effectively reduce the risk of gout and hyperuricemia by stably controlling the patient's uric acid value.
Click to view the full report TOC, figure and tables：
https://www.globalinforesearch.com/global-febuxostat-market_p88575.html
Global Febuxostat Market: Forecast by Type / Application / Region
Febuxostat is a uric acid production inhibitor. It is an activity that can hinder the production of blood uric acid in the body - xanthine oxidase. Then the body normally metabolizes excess uric acid from the body. Therefore, it will not increase the burden of liver and kidney, and patients with low liver and kidney function can also take this drug conveniently.
The worldwide market for Febuxostat is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 1590 million US$ in 2023, from 850 million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Febuxostat in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Global Nonferrous Metal Recycling Market:Key Players
Takeda Pharmaceuticals
MACLEODS
Prinston Pharmaceutical
Alembic Pharmaceuticals
Hikma Pharmaceuticals
Lupin Limited
Mylan
Teijin Pharma
Hengrui Pharma
Sun Pharma
Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-febuxostat-market_p88575.html
Related Information:
United States Febuxostat Market 2018 Forecast to 2023
Europe Febuxostat Market 2018 Forecast to 2023
North America Febuxostat Market 2018 Forecast to 2023
Asia-Pacific Febuxostat Market 2018 Forecast to 2023
China Febuxostat Market 2018 Forecast to 2023
EMEA Febuxostat Market 2018 Forecast to 2023
Global Febuxostat Market 2018 Forecast to 2023
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Contact US :
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Febuxostat Market will reach 1590 million US$ in 2023 here
News-ID: 1386860 • Views: …
More Releases from Global Info Research
Glass Nonwovens Wet-Laid Market: Manufacturer Capacity, Output, Sales, Competiti …
Global Info Research announces the release of the report "Global Glass Nonwovens Wet-Laid Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the Glass Nonwovens Wet-Laid market scenario, including a thorough analysis of the Glass Nonwovens Wet-Laid market size, sales quantity, average price, revenue, gross margin and market share.The Glass Nonwovens Wet-Laid report provides an in-depth analysis of the competitive landscape,…
Global Waterproof Fabrics Industry Chain Analysis Report 2026
On Dec 17, 2025, Global Info Research released a research report titled "Global Waterproof Fabrics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report provides detailed data analysis of the Waterproof Fabrics market from 2021 to 2032. Including the market size and development trends of Waterproof Fabrics Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also…
N-Dodecylphosphonic Acid Market Opportunities, Growth Trends and Demand Analysis …
On Dec 17, Global Info Research released "Global N-Dodecylphosphonic Acid Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report includes an overview of the development of the N-Dodecylphosphonic Acid industry chain, the market status of N-Dodecylphosphonic Acid Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of N-Dodecylphosphonic Acid.
According to our (Global Info Research) latest…
Choline Glycerophosphate Market Demand Analysis Report 2026
On Dec 17, Global Info Research released "Global Choline Glycerophosphate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032". This report includes an overview of the development of the Choline Glycerophosphate industry chain, the market status of Choline Glycerophosphate Market, and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Choline Glycerophosphate.
According to our (Global Info Research) latest…
More Releases for Febuxostat
Febuxostat Market worth $1,699.92 million by 2030, growing at a CAGR of 8.61% - …
The "Febuxostat Market by Formulation (Capsules, Tablets), Application (Chronic Gout Management, Uric Acid Related Conditions), Distribution Channel - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/febuxostat
Febuxostat is a medication primarily used to treat gout and hyperuricemia by inhibiting xanthine oxidase, significantly impacting the pharmaceutical and healthcare markets for conditions caused by elevated uric acid levels. The growing prevalence of lifestyle diseases, such…
Febuxostat Tablets Market Is Likely to Experience a Tremendous Growth by 2029
Febuxostat Tablets Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 23.85% from 2024 to 2030. Amidst the evolving landscape of gout treatment, the Febuxostat tablets market presents abundant growth opportunities for industry stakeholders. Expansion initiatives aimed at increasing product availability and market penetration cater to the growing demand for Febuxostat among healthcare providers and patients.
In order…
Global Febuxostat Tablets Market Size, Growth Rate, Industry Opportunities 2023- …
Global Info Research announces the release of the report "Global Febuxostat Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected…
Febuxostat Market Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Febuxostat Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Febuxostat Market Breakdown by Application (AcuteGout, ChronicGout) by Type (40mg, 80mg, 20mg, 120mg) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Febuxostat Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of…
Febuxostat Market Top Leading Players with Strategies and Forecast 2028
The global Febuxostat market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Febuxostat, a xanthine oxidase inhibitor, was approved by the FDA in 2009 for the long-term treatment of hyperuricemia in gout patients. Febuxostat drug is a medication that is used to treat gout by reducing uric acid levels. Due to the obvious risk of serious heart problems and stroke with febuxostat, it should only…
Global Febuxostat Market 2017 - Pure Chemistry Scientific, LGM Pharma, BOC Scien …
Febuxostat Market Research Report
A market study based on the " Febuxostat Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Febuxostat Market 2017’. The research report analyses the historical as well as present performance of the worldwide Febuxostat industry, and makes predictions on the future status of Febuxostat market on the basis of this analysis.
Request For Sample Copy of Report : http://bit.ly/2reiEdN
Top…
